October 15, 2024
TOPLINE: Youths with type 1 diabetes (T1D) show lower bone accrual than expected for their age, gender, pubertal stage, lean mass accrual, and growth, with greater […]
October 14, 2024
Pamela Goodwin has received hundreds of emails from patients asking if they should take a cheap, readily available drug, metformin, to treat their cancer. It’s a […]
October 14, 2024
A new review found that a genetic condition that puts people at a risk for high cholesterol is not protective against type 2 diabetes (T2D), despite […]
October 14, 2024
TOPLINE: There is no universally accepted definition for recurrence of differentiated thyroid cancer (DTC) across treatment categories such as total thyroidectomy with or without radioactive iodine […]
October 14, 2024
TOPLINE: Long-term exposure to fine particulate matter (PM2.5) and nitrogen dioxide (NO2) increases cause-specific mortality in those with type 2 diabetes (T2D), whereas increased green space […]
October 11, 2024
Metabolic-bariatric surgery (MBS) appears to lower the risk for pancreatic cancer in people with obesity, with a potentially greater effect in those who also have type […]
October 10, 2024
Papillary thyroid cancer is widely known as the “good cancer.” This term has been around for years and is used ubiquitously. Some think it’s “appropriate” because […]
October 10, 2024
TOPLINE: Lower preoperative levels of triglycerides and high-density lipoprotein (HDL) cholesterol are linked to higher recurrence rates in patients with papillary thyroid cancer, suggesting that preoperative […]
October 10, 2024
TOPLINE: Continuous glucose monitoring (CGM) combined with geriatric principles of simplified treatment regimens and personalized glycemic goals reduces hypoglycemia duration in older adults with type 1 diabetes […]